Profiel
Patric Trojer served as the Chief Scientific Officer at Constellation Pharmaceuticals, Inc. from 2018 to 2021.
Prior to that, he held other positions at the same company from 2008.
Trojer received a graduate and doctorate degree from the University of Innsbruck.
Eerdere bekende functies van Patric Trojer
Bedrijven | Functie | Einde |
---|---|---|
CONSTELLATION PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 15-07-2021 |
Opleiding van Patric Trojer
University of Innsbruck | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Constellation Pharmaceuticals, Inc.
Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics. The firm utilizes epigenetics platform, which enables to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity. Its product include CPI-0610, CPI-1205, and CPI-0209. The company was founded by Danny Reinberg, David Allis, and Yang Shi on January 11, 2008 and is headquartered in Cambridge, MA. | Health Technology |